Literature DB >> 6157772

Severity of lymphocytic choriomeningitis virus disease in different strains of suckling mice correlates with increasing amounts of endogenous interferon.

Y Rivière, I Gresser, J C Guillon, M T Bandu, P Ronco, L Morel-Maroger, P Verroust.   

Abstract

A marked difference was observed in the severity of disease in lymphocytic choriomeningitis (LCM) virus-infected suckling BALB/c, Swiss, and C3H mice. BALB/c mice had minimal liver lesions and none died, whereas C3H mice had extensive liver lesions and all mice died. An intermediate pattern was oberved for Swiss mice (36% mortality). Although there was no difference in the titers of LCM virus in the plasma or liver between these three strains of mice, there was a marked difference in the amount of interferon produced and the duration of interferonemia. C3H mice produced more interferon than Swiss mice which produced more interferon than BALB/c mice, indicating a direct correlation between the amount of interferon induced by LCM virus and the extent of disease. Inoculation of a potent anti-mouse interferon globulin markedly reduced the incidence of mortality in virus-infected C3H mice. BALB/c mice were as sensitive to the effects of interferon as C3H mice because daily administration of potent interferon preparations did induce disease in this strain. This ensemble of results supports our contention that endogenous interferon is in large part responsible for the manifestaions of acute LCM virus disease in suckling mice.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6157772      PMCID: PMC2185917          DOI: 10.1084/jem.152.3.633

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

1.  Protective effect of pre-irradiation on lymphocytic choriomeningitis infection in mice.

Authors:  W P ROWE
Journal:  Proc Soc Exp Biol Med       Date:  1956-05

2.  Change in susceptibility of C3H-HeJ mice to LCM virus infection.

Authors:  M B Oldstone; F J Dixon
Journal:  J Immunol       Date:  1973-11       Impact factor: 5.422

3.  A locus affecting circulating interferon levels induced by mouse mammary tumour virus.

Authors:  E de Maeyer; J de Maeyer-Guignard; W T Hall; D W Bailey
Journal:  J Gen Virol       Date:  1974-05       Impact factor: 3.891

4.  A comparison of the efficacy of endogenous, exogenous, and combined endogenous-exogenous interferon in the treatment of mice infected with encephalomyocarditis virus.

Authors:  I Gresser; D Fontaine-Brouty-Boyé; C Bourali; M T Thomas
Journal:  Proc Soc Exp Biol Med       Date:  1969-01

5.  A method for the large scale production of potent interferon preparations.

Authors:  M G Tovey; J Begon-Lours; I Gresser
Journal:  Proc Soc Exp Biol Med       Date:  1974-07

6.  Diversity of lymphocytic choriomeningitis virus: variation due to replication of the virus in the mouse.

Authors:  M Popescu; F Lehmann-Grube
Journal:  J Gen Virol       Date:  1976-01       Impact factor: 3.891

7.  Enhancement of IgE-mediated histamine release from human basophils by viruses: role of interferon.

Authors:  S Ida; J J Hooks; R P Siraganian; A L Notkins
Journal:  J Exp Med       Date:  1977-04-01       Impact factor: 14.307

8.  Multiplication of lymphocytic choriomeningitis virus in cultivated foetal inbred mouse cells and in neonatally infected inbred carrier mice.

Authors:  H von Boehmer; F Lehmann-Grube; R Flemer; R Heuwinkel
Journal:  J Gen Virol       Date:  1974-11       Impact factor: 3.891

9.  Inhibition by anti-interferon serum of lymphocytic choriomeningitis virus disease in suckling mice.

Authors:  Y Rivière; I Gresser; J C Guillon; M G Tovey
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

10.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection.

Authors:  I Gresser; M G Tovey; M E Bandu; C Maury; D Brouty-Boyé
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

View more
  19 in total

1.  Mucosal immunization with Salmonella typhimurium expressing Lassa virus nucleocapsid protein cross-protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  M Djavani; C Yin; I S Lukashevich; J Rodas; S K Rai; M S Salvato
Journal:  J Hum Virol       Date:  2001 Mar-Apr

2.  Genetic reassortants of lymphocytic choriomeningitis virus: unexpected disease and mechanism of pathogenesis.

Authors:  Y Riviere; M B Oldstone
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

3.  A Brief Historical Perspective on the Pathological Consequences of Excessive Type I Interferon Exposure In vivo.

Authors:  Yanick J Crow; Pierre Lebon; Jean-Laurent Casanova; Ion Gresser
Journal:  J Clin Immunol       Date:  2018-09-05       Impact factor: 8.317

4.  Interferon structural genes do not participate in quantitative regulation of interferon production by If loci as shown in C57BL/6 mice that are congenic with BALB/c mice at the alpha interferon gene cluster.

Authors:  J De Maeyer-Guignard; F Dandoy; D W Bailey; E De Maeyer
Journal:  J Virol       Date:  1986-06       Impact factor: 5.103

5.  Characterization of a nonvirulent variant of lymphocytic choriomeningitis virus.

Authors:  P R Brayton; H F Maassab
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

Review 6.  Expression of the genes of interferons and other cytokines in normal and diseased tissues of man.

Authors:  M G Tovey
Journal:  Experientia       Date:  1989-06-15

7.  Antibody to mouse alpha/beta interferon abrogates Pichinde virus-induced liver lesions in suckling mice.

Authors:  T Clark; I Gresser; C Pfau; J Moss; D Woodrow
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

8.  Lymphocytic choriomeningitis infection in the nude mouse. An immunopathological study.

Authors:  P Ronco; Y Rivière; Y Thoua; M T Bandu; J C Guillon; P Verroust; L Morel-Maroger
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

9.  Immune interferon in serum and synovial fluid in rheumatoid arthritis and related disorders.

Authors:  M DeGré; O J Mellbye; O Clarke-Jenssen
Journal:  Ann Rheum Dis       Date:  1983-12       Impact factor: 19.103

10.  Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies.

Authors:  T H Bacon; A de Vere-Tyndall; D A Tyrrell; A M Denman; B M Ansell
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.